BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1662891)

  • 21. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1515-6. PubMed ID: 1929320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
    Cohen MA; Huband MD
    J Antimicrob Chemother; 1997 Aug; 40(2):308-9. PubMed ID: 9302005
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycoplasma hominis and Ureaplasma urealyticum in patients with sexually transmitted diseases.
    Koch A; Bilina A; Teodorowicz L; Stary A
    Wien Klin Wochenschr; 1997 Aug; 109(14-15):584-9. PubMed ID: 9286064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas.
    Bébéar CM; Renaudin H; Boudjadja A; Bébéar C
    Antimicrob Agents Chemother; 1998 Mar; 42(3):703-4. PubMed ID: 9517957
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Paukner S; Gruss A; Jensen JS
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent developments in the treatment of sexually transmitted diseases.
    Mogabgab WJ
    Am J Med; 1991 Dec; 91(6A):140S-144S. PubMed ID: 1767802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the bactericidal activity of temafloxacin.
    Jacobs MR
    Am J Med; 1991 Dec; 91(6A):31S-34S. PubMed ID: 1662893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum.
    Maeda S; Tamaki M; Kubota Y; Nguyen PB; Yasuda M; Deguchi T
    Int J Urol; 2007 May; 14(5):422-5. PubMed ID: 17511725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly specific and efficient primers for in-house multiplex PCR detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis and Ureaplasma urealyticum.
    Aguilera-Arreola MG; González-Cardel AM; Tenorio AM; Curiel-Quesada E; Castro-Escarpulli G
    BMC Res Notes; 2014 Jul; 7():433. PubMed ID: 24997675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of temafloxacin compared with those of other agents against 100 clinical isolates of Neisseria gonorrhoeae.
    Glatt AE; Cummings M; McCormack W
    Antimicrob Agents Chemother; 1992 May; 36(5):1131-2. PubMed ID: 1324638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
    Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
    Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A New Multiplex Genetic Detection Assay Method for the Rapid Semi-Quantitative Detection of Six Common Curable Sexually Transmitted Pathogens From the Genital Tract.
    Sun Z; Meng J; Wang S; Yang F; Liu T; Zeng X; Zhang D; Zhu H; Chi W; Liu Y; Jiang W; Ding L; Miao Y; Wu Y; Zhao H; Zhang Y
    Front Cell Infect Microbiol; 2021; 11():704037. PubMed ID: 34497776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiological and therapeutic study on urethritis of male and cervicitis from viewpoint of STD--a study using NY-198. Sapporo Clinical Research Group for STD].
    Kumamoto Y; Miyagishi T; Hirose T; Hayashi K; Gohro T; Ueno T; Mohri K; Kodama N; Abe K
    Hinyokika Kiyo; 1990 Aug; 36(8):979-87. PubMed ID: 2122659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of clindamycin against strains of Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum isolated from pregnant women.
    Harrison HR; Riggin RM; Alexander ER; Weinstein L
    Am J Obstet Gynecol; 1984 Jul; 149(5):477-80. PubMed ID: 6742014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temafloxacin: an overview.
    Pankey GA
    Am J Med; 1991 Dec; 91(6A):166S-172S. PubMed ID: 1662889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals].
    Farkas B; Ostorházi E; Pónyai K; Tóth B; Adlan E; Párducz L; Marschalkó M; Kárpáti S; Rozgonyi F
    Orv Hetil; 2011 Oct; 152(42):1698-702. PubMed ID: 21979223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial causative agents of male urethritis.
    Stefánik M; Rychna K; Valkoun A
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):111-8. PubMed ID: 1619287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men.
    Totten PA; Schwartz MA; Sjöström KE; Kenny GE; Handsfield HH; Weiss JB; Whittington WL
    J Infect Dis; 2001 Jan; 183(2):269-276. PubMed ID: 11120932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.
    Kenny GE; Hooton TM; Roberts MC; Cartwright FD; Hoyt J
    Antimicrob Agents Chemother; 1989 Jan; 33(1):103-7. PubMed ID: 2712541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-chlamydial non-gonococcal urethritis].
    Deguchi T; Yasuda M; Maeda S
    Nihon Rinsho; 2009 Jan; 67(1):167-71. PubMed ID: 19177768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.